TRIM32 Regulates Skeletal Muscle Stem Cell Differentiation and Is Necessary for Normal Adult Muscle Regeneration by Nicklas, Sarah et al.
TRIM32 Regulates Skeletal Muscle Stem Cell
Differentiation and Is Necessary for Normal Adult Muscle
Regeneration
Sarah Nicklas
1., Anthony Otto
3., Xiaoli Wu
2, Pamela Miller
2, Sandra Stelzer
1, Yefei Wen
4, Shihuan
Kuang
4, Klaus Wrogemann
2, Ketan Patel
3, Hao Ding
2*, Jens C. Schwamborn
1*
1Westfa ¨lische Wilhelms-Universita ¨tM u ¨nster, Zentrum fu ¨r Molekularbiologie der Entzu ¨ndung, Institute of Cell Biology, Stem Cell Biology and Regeneration Group,
Mu ¨nster, Germany, 2Department of Biochemistry and Medical Genetics, University of Manitoba, Winnipeg, Manitoba, Canada, 3School of Biological Sciences, University
of Reading, Whiteknights Campus, Reading, United Kingdom, 4Department of Animal Sciences, Purdue University, West Lafayette, Indiana, United States of America
Abstract
Limb girdle muscular dystrophy type 2H (LGMD2H) is an inherited autosomal recessive disease of skeletal muscle caused by
a mutation in the TRIM32 gene. Currently its pathogenesis is entirely unclear. Typically the regeneration process of adult
skeletal muscle during growth or following injury is controlled by a tissue specific stem cell population termed satellite cells.
Given that TRIM32 regulates the fate of mammalian neural progenitor cells through controlling their differentiation, we
asked whether TRIM32 could also be essential for the regulation of myogenic stem cells. Here we demonstrate for the first
time that TRIM32 is expressed in the skeletal muscle stem cell lineage of adult mice, and that in the absence of TRIM32,
myogenic differentiation is disrupted. Moreover, we show that the ubiquitin ligase TRIM32 controls this process through the
regulation of c-Myc, a similar mechanism to that previously observed in neural progenitors. Importantly we show that loss
of TRIM32 function induces a LGMD2H-like phenotype and strongly affects muscle regeneration in vivo. Our studies
implicate that the loss of TRIM32 results in dysfunctional muscle stem cells which could contribute to the development of
LGMD2H.
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Introduction
Limb girdle muscular dystrophies (LGMDs) are a group of
inherited disorders that progressively lead to muscle weakness and
wasting predominantly in the shoulder and pelvic girdle. Seven
types with an autosomal dominant mode of inheritance and 14
autosomal recessive forms have been currently identified [1]. A
homozygous mutation in the gene for the protein TRIM32
(D487N) has been linked to LGMD type 2H which was originally
identified in the Hutterite population of the North American
Prairies [2]. Additional mutations in the TRIM32 gene leading to
LGMD2H have also been found recently in other populations [3],
[4], implicating the causative role of TRIM32 in the pathogenesis
of LGMD2H. Recently it has been shown that the D489N
pathogenic mutation destabilizes the TRIM32 protein, leading to
its degradation [5]. Consequently, a potential mechanism of
LGMD2H pathology might be the destabilization of mutated
TRIM32 protein leading to a null phenotype.TRIM32 belongs to
the TRIM-NHL family that is characterized by the presence of an
N-terminal RING finger, one or more Zinc-finger-like motifs
called B-boxes, a coiled coil region and a C-terminal NHL domain
[6]. All of the identified LGMD2H mutations are located in the C-
terminal NHL domain [2], [3], [4]. Recently, we have
demonstrated that TRIM32 is involved in the regulation of
differentiation and self-renewal in neural progenitor cells during
mouse embryonic brain development [7] [8]. Additionally, the
Drosophila orthologs of TRIM32, Brat and the Brat-like protein
Mei-P26 control stem cell proliferation in the Drosophila nervous
system and ovaries, respectively [9], [10], [11], [12], [13]. Thus,
control of stem cell proliferation might be a common function of
TRIM-NHL proteins and deregulation of muscle stem cell activity
upon loss of TRIM32 could contribute to the formation of
LGMD2H.
Stem cells of the adult muscle are termed satellite cells. These
mononucleated cells are localized between the sarcolemma of the
myofiber and the basal membrane that surrounds each muscle
fiber [14]. Satellite cells display all the characteristics associated
with stem cells, they are able to self-renew and to give rise to
PLoS ONE | www.plosone.org 1 January 2012 | Volume 7 | Issue 1 | e30445progeny that can undergo myogenic differentiation in vitro and in
vivo [15], [16]. Following injury to skeletal muscle, quiescent
satellite cells surrounding the damaged myofibers are activated
and proliferate forming huge numbers of myoblast progeny cells
which then differentiate and are either incorporated into existing
damaged myofibers or undergo fusion with each other forming
new myofibers [15]. A subset of these expanded progeny cells do
not undergo differentiation and revert back to the quiescent state
thus re-establishing the stem cell pool on the newly formed
myofibers [17]. These characteristics enable satellite cells to
regenerate damaged muscle as well as permitting growth.
A most recent study has suggested that the skeletal muscle
pathology observed in TRIM32 deficient mice could be a
consequence of abnormalities in neuronal tissue [18]. However,
the potential role for TRIM32 in directly regulating skeletal
muscle stem cells has yet to be examined. Here, we demonstrated
for the first time that TRIM32 expression is temporally regulated
during satellite cell progeny expansion and is strongly induced
during muscle differentiation in vitro and during muscular
regeneration in vivo. We could show that TRIM32 is necessary
and sufficient for myoblast differentiation in muscle progenitor
cells which depends on the ubiquitination and degradation of its
binding partner c-Myc. Finally, using two different lines of
TRIM32 null mice, we showed that loss of TRIM32 function
causes a LGMD2H-like phenotype which is associated with
dysfunctional muscle satellite cells. Moreover, skeletal muscle
regeneration is greatly impaired in these mice, indicating an
important role for TRIM32 in the regulation of skeletal muscle
stem cells.
Results
TRIM32 is expressed in proliferating and differentiating
myogenic cells
Previously, we have demonstrated that TRIM32 is necessary
and sufficient for the differentiation of neural progenitor cells [7].
However, whether TRIM32 is also required for the differentiation
of myogenic stem cells is largely unknown. As a first approach, we
applied a well-established in vitro myofiber culture system to
determine the dynamic expression of TRIM32 during the
proliferation and differentiation of satellite cells.
It has been shown previously, that TRM32 is expressed in
mature muscle fibers [16]. In agreement with this observation we
also saw a significant expression of TRIM32, showing a typical
stripe-like patter, in isolated muscle fibers (Fig. S1). However, we
were actually interested in the expression of TRIM32 in muscle
progenitor cells. As in previous studies from ourselves and others,
quiescent and non-committed satellite cells were marked using
Pax7 immunoreactivity, proliferating cells were marked with Pax7
and MyoD and differentiating cells were labelled with Myogenin
[17], [19], [16]. On freshly isolated mouse myofibers (at time point
0 h) harbouring quiescent satellite cells, around 90% of Pax7
+ cells
were negative for TRIM32, suggesting that TRIM32 is unlikely to
be expressed in the quiescent satellite cell (Fig. 1a and b).
However, 10% of satellite cells at this time point showed
immunoreactivity for TRIM32 (Fig. 1a and b), which could
reflect a small population of satellite cells that are activated upon
muscle sample dissection (see discussion). Between 24 and 72 h of
cultivation, satellite cells on isolated myofibers become activated,
start to proliferate and produce clones of increasing size (Fig. 1a).
Following 24 h of culture, when satellite cells are activated (100%
of cells were positive for MyoD), 98.2% of satellite cells also
showed double staining for Pax7 and TRIM32 (Fig. 1a and b).
Interestingly these cells displayed a strong nuclear TRIM32 signal
(Fig. 1a). After 48 and 72 h, high TRIM32 expression was also
found in Myogenin
+ cells (Fig. 1a, b and Fig. S1), demonstrating
that TRIM32 is induced in activated satellite cells and also highly
expressed in differentiating myoblasts. At 72 h, we also identified a
group of cells (3.1%) that were Pax7
+ but negative for TRIM32.
These cells might have reverted back towards quiescence to
replenish the pool of satellite cells, further indicating that TRIM32
is not expressed in quiescent satellite cells. At both the 48 and 72 h
time points, all TRIM32 positive cells showed an additional strong
cytoplasmic TRIM32 staining (Fig. 1a), suggesting a trafficking of
TRIM32 during satellite cell-differentiation. However, the phys-
iological relevance of this trafficking is currently unknown. To
further prove the specificity of the described stainings, we used two
other independent anti-TRIM32 antibodies that gave similar
results (Fig. S1).
To address whether the above described expression pattern of
TRIM32 in the myogenic lineage could be conserved between
mice and primates, we analyzed the expression of TRIM32 in
muscle fibers from the common marmoset Callithrix jacchus. Again,
TRIM32 was only detected in the proliferating and differentiating
satellite cells (Fig. S2).
Previous work has established that similar cellular mechanisms
are involved in regulating both embryonic and foetal muscle
growth and adult skeletal muscle regeneration [20], [19], [21]. In
order to investigate whether TRIM32 is also involved in both
stages of tissue development we analysed the expression of
TRIM32 during primary (E14.5) and secondary (E18.5) myofiber
formation, two key phases of murine skeletal muscle development
in the embryo. We found that TRIM32 is expressed during mouse
foetal skeletal muscle development in both differentiating progeny
cells and newly formed myofibers identified through Myogenin
and MHC type I co-staining, respectively (Fig. S3), suggesting the
role for TRIM32 in adult skeletal muscle may be re-capitulated in
the embryo.
TRIM32 is strongly expressed during muscle regeneration
To determine whether TRIM32 expression is induced in
proliferating satellite cells or myoblast cells in vivo, we analyzed the
expression of TRIM32 during cardiotoxin (CTX)-induced muscle
regeneration. Injection of CTX causes massive myofiber damage
and subsequent necrosis followed by a period of extensive satellite
cell proliferation and differentiation [15]. Following 3 and 7 days
post injection, the regeneration response is at its highest as many
infiltrating cells and proliferating myoblasts are apparent that
surround newly forming skeletal muscle fibers (marked by fibers
displaying centrally located nuclei) (Fig. 2). Using an RNA in situ
hybridization approach, we observed markedly up-regulated
TRIM32 mRNA in areas of regenerating myofibers, but not in
non-regenerating muscle tissue 3 days post injection (Fig. 2b and
d). On day 7 post CTX injection, the newly forming myofibers
with centrally located nuclei also showed strong staining for
TRIM32 (Fig. 2f), suggesting that recently activated and fusing
myogenic precursors express TRIM32 in vivo.
Taken together, this part of our work demonstrates that
TRIM32 expression is highly induced during the activation of
muscle satellite cells and is closely associated with muscle
differentiation in vivo.
Loss of TRIM32 function inhibits the differentiation of
muscle satellite cells
To further investigate the role of TRIM32 in muscle satellite
cells, we firstly applied a gene-targeting approach to create
TRIM32 null mutant mice in which the whole TRIM32 coding
sequence (Exon 2) was deleted (Fig. S4). A complete loss of
TRIM32 in Satellite Cells
PLoS ONE | www.plosone.org 2 January 2012 | Volume 7 | Issue 1 | e30445Figure 1. TRIM32 is expressed in satellite cells during regeneration in vitro. (a) Immunostainings of satellite cells on myofibers from wild
type mice cultured for the indicated time (left grey boxes) and labelled with the indicated markers (upper grey boxes). The right panels show single
nuclei in higher magnification. Note that here the anti-TRIM32 antibody 1137 (see methods) has been used. (b) Diagram showing the fraction of cells
at each culture time point that were double-positive for TRIM32/Pax7, TRIM32/MyoD or TRIM32/Myogenin.
doi:10.1371/journal.pone.0030445.g001
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Western blot analysis (Fig. S4) and by Northern hybridization
(data not shown). We then obtained single muscle fibers from these
mutant mice to determine whether loss of TRIM32 function will
affect the differentiation of muscle satellite cells. Additionally, we
made use of TRIM32 null mice that recently have been described
[18].
On fibers from TRIM32+/+ mice at 24 h of cultivation, only
10.0% of the satellite cells (Pax7 positive) were still negative for
MyoD, while all the others were co-stained with Pax7 and MyoD,
indicating that the majority of TRIM32+/+ satellite cells
underwent differentiation at 24 h of cultivation. In contrast, at
the same time point on fibers from TRIM322/2 mice, 44.1% of
the Pax7 positive satellite cells were still negative for MyoD (Fig. 3a
and b). This result indicates that the TRIM32 deficient satellite
cells are delayed in initiating the myogenic differentiation
program. This assumption is further supported by the observations
from fibers that were cultivated for 48–72 h. At 48 h, only 8.0% of
the satellite cells and their progeny were still negative for the
muscle differentiation marker Myogenin on TRIM32+/+ myofi-
bers, . In contrast, in the absence of TRIM32, 37.2% of the Pax7
positive cells were still negative for Myogenin (Fig. 3c and d).
Consequently, at 72 h of cultivation already 17.8% of the
progenitor cells on wild type fibers had downregulated Pax7 (they
are Myogenin
+/Pax7
2), while only 3.9% of the TRIM32 deficient
progenitor cells were able to undergo this terminal differentiation
at this time point (Fig. 3e and f). Additionally, a significant increase
in apoptosis was observed in fiber cultures from TRIM32 deficient
mice during myogenic differentiation (Fig. S6).
Therefore, our data strongly indicate that loss of TRIM32
function inhibits the differentiation and maturation of muscle
satellite cells.
Figure 2. TRIM32 is induced during muscle regeneration in vivo. (a) and (c) Hematoxylin and Eosin (H&E) staining of regenerating TA muscle
from wild type mice 3 days post cardiotoxin (CTX) injection. Arrows in (a) indicate the regions of CTX-induced muscle regeneration. (c) shows
enlarged region of the boxed area in (a). (b) and (d) RNA in situ hybridization showing TRIM32 expression (blue) in wild type mouse TA muscle 3 days
post CTX injection. (d) shows enlarged regions of the boxed area in (b). (e) H&E staining of regenerating TA muscle from wild type mice 7 days post
CTX injection. (f) RNA in situ hybridization showing TRIM32 expression (blue) in wild type mouse TA muscle 7 days post CTX injection.
doi:10.1371/journal.pone.0030445.g002
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progenitor cells
Since TRIM32 expression is significantly increased during the
differentiation of C2C12 muscle progenitor cells (Fig. S5), we
explored this well-characterized cell line to further characterize the
role of TRIM32 in myogenic differentiation. It has been shown
that the LGMD2H causing D489N mutation in TRIM32 [2]
destabilizes the TRIM32 protein and leads to its degradation [5].
Consequently, a reduction of TRIM32 levels by an RNAi
approach is suitable to model the disease situation. Therefore,
we introduced TRIM32 overexpressing or RNAi constructs (both
with an EGFP-tag) into C2C12 cells which were then differenti-
ated for two days and stained for the differentiation marker
Myosin heavy chain (MHC). In these assays, only transfected cells
labeled by EGFP were analyzed. As shown in Figure 4, 33.7% of
C2C12 cells transfected with a vector expressing only EGFP
underwent muscle differentiation. However, upon transfection of
TRIM32-EGFP, muscle differentiation was strongly increased, as
78.8% of the cells were positive for Myosin. Upon knock-down of
TRIM32 by using two functional independent hairpin RNAi
constructs against TRIM32, a strong inhibition of muscle
differentiation was observed (shRNA #1: 14.2%; shRNA #2:
19.6%, as compared to 33% in control group) (Fig. 4a and b).
Figure 3. Differentiation is strongly reduced in satellite cell progeny on TRIM322/2 myofibers. (a), (c) and (e) Immunostainings of
satellite cells on freshly isolated myofibers from wild type (+/+) and TRIM322/2 (2/2) mice cultured for 24 h (a), 48 h (c) and 72 h (e) and labelled
with the indicated markers (upper grey boxes). (b), (d) and (f) Diagrams showing the relative frequency of Pax7
+/MyoD
2 cells on fibers cultured for
24 h (b), Pax7
+/Myogenin
2 cells on fibers cultured for 48 h (d) and Pax7
2/Myogenin
+ cells on fibers cultured for 72 h (f). In all cases cells on myofibers
from wild type mice and TRIM322/2 mice are compared. (mean 6 std; *P,0.001 compared to wild type).
doi:10.1371/journal.pone.0030445.g003
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to induce the differentiation of C2C12 myoblast cells while upon
knock-down of TRIM32 the differentiation of these cells is
inhibited.
c-Myc mediates TRIM32 induced muscle differentiation
We then sought to demonstrate how TRIM32 is involved in the
differentiation of myoblasts by using the C2C12 cell culture
system. Previously we have shown that TRIM32 can ubiquitinate
c-Myc, targeting the protein for breakdown and that this
degradation of c-Myc is critical for differentiation in neural
progenitor cells [7]. Furthermore, c-Myc has been demonstrated
to block the action of MyoD- and Myogenin-mediated skeletal
muscle stem cell differentiation [22]. Therefore, we firstly asked
whether TRIM32 is also able to mediate poly-ubiquitination of c-
Myc in C2C12 cells. Indeed, when TRIM32 and c-Myc are
coexpressed in C2C12 a strong poly-ubiquitination of c-Myc is
detectable (Fig. S7). In contrast this poly-ubiquitination is no
longer detectable when the TRIM32 C24A mutant that has no
ubiquitin ligase activity [7] is expressed. Furthermore, poly-
ubqiutination of c-Myc is detectable during differentiation of
C2C12 cells (Fig. S7b). Therefore, we conclude that TRIM32 is
directly poly-ubiquitinating c-Myc in muscle progenitor cells. Next
we asked whether the regulation of c-Myc by TRIM32 could be
required for the differentiation of C2C12 myoblast cells. To this
end, we overexpressed TRIM32 or TRIM32 C24A in C2C12 cells
and differentiated these cells for 2 days. In control cells, expressing
only EGFP 33.7% of the EGFP transfected cells were positive for
the differentiation marker Myosin. In contrast expression of wild-
type TRIM32 induces differentiation in 78.8% of the cells (Fig. 5a
and b). To characterize whether ubiquitination of c-Myc by
TRIM32 is indeed involved in the TRIM32-induced muscle
differentiation, we knocked down c-Myc with RNAi constructs
and combined this knock-down with the overexpression of the
ubiquitin ligase defective TRIM32 C24A mutant). Overexpression
of TRIM32 C24A alone did not increase muscular differentiation
(only 18.4% of the C2C12 cells expressed Myosin). However,
when the TRIM32 C24A expressing vector was co-transfected
with knock-down constructs for c-Myc in C2C12 cells, 69.3% of
transfected cells differentiated (Fig. 5a and b). Interestingly, knock-
down of c-Myc alone was not sufficient to induce muscular
differentiation. These results support the model that TRIM32
induces differentiation by marking c-Myc for degradation via the
ubiquitin-proteasome-system. However, they also clearly show
that TRIM32 has a second, ubiquitin-ligase independent function
that is important to support differentiation (see discussion).
TRIM32 deficient mice develop a LGMD2H-like myopathy
Thus far we have demonstrated that TRIM32 is expressed in
proliferating and differentiating skeletal muscle stem cells and is
necessary for their normal lineage progression into mature MHC-
expressing myofibers. Moreover we provide evidence that
TRIM32 induces the differentiation of skeletal muscle progenitor
cells through the degradation of c-Myc via the ubiquitination
pathway. Recently, it has been shown that TRIM32 deficient mice
harbour a phenotype similar to that observed in LGMD2H [18].
However, it is unknown whether this phenotype could be brought
about through abnormal skeletal muscle stem cell behaviour.
To address this, we firstly performed extensive histological
analyses on our established TRIM32 null mice to determine
whether these mutant mice develop a similar myopathy as seen in
human LGMD2H patients.
We then analyzed the status of muscle satellite cells in
TRIM322/2 mice at different postnatal developmental stages.
We found that one-month-old TRIM322/2 mice had signifi-
cantly increased numbers of Pax7
+ satellite cells as compared to
wild type controls (Fig. 6b, c and f). These cells were MyoD
negative, indicating they were not induced by muscle regenera-
tion. Therefore we conclude that a dysregulated satellite cell
proliferation occurred in the absence of TRIM32. Interestingly,
Figure 4. TRIM32 is necessary and sufficient to induce muscular differentiation. (a) Myoblast C2C12 cells were transfected with the
indicated constructs (left grey boxes) and cultivated for three days in 2.5% HS. Immunostainings of the cells labelled with the indicated markers
(upper grey boxes) are shown. (b) Diagram showing the fraction of transfected cells that undergo muscular differentiation (Myosin positive). (mean 6
std; *P,0.001 compared to EGFP).
doi:10.1371/journal.pone.0030445.g004
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basal lamina (normally satellite cells are all beneath the basal
lamina) (Fig. 6d and e), In 2–3 month-old TRIM32 mutant mice,
we did not find the increased number of Pax7
+ satellite cells, but
we still observed numerous satellite cells mis-located in the
interstitial space (data not shown). These data clearly demonstrate
that loss of TRIM32 function causes abnormal muscle stem cell
behavior in vivo.
TRIM32 deficient mice show delayed skeletal muscle
regeneration
To further determine whether the satellite cells in TRIM322/2
mice are capable of providing myoblasts which will undergo
normal muscle regeneration, we carried out a similar set of
experiments using the CTX-induced muscle injury model and
compared the regenerative response in both wild type and
TRIM322/2 TA muscles respectively. Strikingly, we observed a
delay in the regeneration response in the absence of TRIM32,
whereby TA muscles 5 days post-injection of CTX displayed
smaller newly formed myofibers and showed larger regions of
tissue containing infiltrating cells (compare Fig. 7a to b and c to d).
Moreover, 16 days post injection, when wild type control skeletal
muscle has fully regenerated and only harbors few centrally
located myonuclei, TRIM322/2 muscle continued to display
regions of non-regenerated myofibers that contained many single
cells with the characteristics of cellular infiltrate (Fig. 7e–h).
Finally, when we looked at 16-days post injection, we observed the
formation of adipocyte-like cells within the muscle tissue of
TRIM322/2 animals. These cells were never seen in wild type
muscle (Fig. 7e and f). Similar results were obtained after CTX
injection in gastrocnemius muscles (unpublished data). Taken
together, these data show that TRIM32 is essential for the normal
progression of skeletal muscle regeneration in vivo and that loss of
TRIM32 function, by perturbing the differentiation of myoblast
cells into muscle, may lead to the conversion of these cells into
other lineages.
Discussion
In this work, we investigated the function of TRIM32, a gene
that is often mutated in patients with LGMD2H, during skeletal
muscle regeneration. Our data has revealed a number of novel
findings which extend our understanding of skeletal muscle stem
cell biology and provide an explanation for the LGMD2H
phenotype. Firstly, we have shown that TRIM32 is upregulated
in muscle stem cells (satellite cells) during their proliferation and
differentiation, and this upregulation was also observed in
regenerating muscles in which muscle satellite cells are actively
involved. Interestingly, this dynamic expression pattern is also
conserved in the common marmoset Callithrix jacchus. Using
different approaches, we have further demonstrated that TRIM32
is involved in muscle differentiation and that this differentiation
probably depends on the ubiquitination and degradation of c-Myc.
Finally, we provided evidence that TRIM32 knock-out mice
developed a myopathy similar to that presented by LGMD2H
patients and that muscle regeneration in these mice was greatly
delayed and impaired. Based on these experimental findings, we
propose that loss of TRIM32 function in the muscle stem cells will
impair their functionality. This dysfunction of the muscle stem
cells could be the main cause for the aetiology of LGMD2H.
Figure 5. Degradation of c-Myc is critical for TRIM32 induced differentiation. (a) C2C12 cells were transfected with the indicated constructs
(left grey boxes) and cultivated for three days in 2.5% HS. Immunostainings of the cells labelled with the indicated markers (upper grey boxes) are
shown. (b) Diagram showing the fraction of transfected cells that undergo muscular differentiation (Myosin positive). (mean 6 std; *P,0.001
compared to EGFP).
doi:10.1371/journal.pone.0030445.g005
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frequently occur and are repaired by satellite cells. However, in
TRIM32 deficient mice or in LGMD2H patients, satellite cells and
their progeny are not able to properly differentiate into mature
muscle cells and therefore lesions are not repaired. As a
consequence, the status of the muscle becomes progressively
worse over time until it becomes apparent as a dystrophy.
In this study, we present a temporal and spatial expression
analysis for TRIM32 during the lineage progression of satellite
cells. In 90% of quiescent satellite cells we observed no TRIM32
expression, which strongly indicated that TRIM32 is not expressed
in this specific cell population. However, we do find that around
10% of these cells express TRIM32. Two possible explanations for
this are apparent. Either TRIM32 is expressed in a subset of
resting satellite cells (an unlikely explanation as we failed to find
TRIM32 expression on resting muscle transverse sections) or
TRIM32 is initiated very early in the regenerative response to
injury. This second explanation is more likely as myofibers take at
least 2 h to be isolated and fixed, enough time to initiate the
expression of a protein as previously observed in the case of
MyoD, that is initiated just 2 h following myofiber culture [19]. By
48 h post-myofiber isolation, when most progeny cells are
proliferating [17], all progeny express TRIM32. Moreover, low
levels of TRIM32 were observed in proliferating C2C12 cells,
suggesting that TRIM32 is not inhibitory to proliferation at lower
levels. However, as myoblasts differentiate TRIM32 is upregu-
lated, as we have observed in C2C12 cells. Interestingly, we
observed four distinct populations of myogenic cells following 72 h
of single myofiber culture. The largest subset of TRIM32
+ cells at
this time point co-expressed the differentiation marker Myogenin,
however Pax7
+/Myogenin
2 cells also showed TRIM32 expression
at this stage. Interestingly, a small subset of non-differentiated
Pax7
+ cells were noted that were also negative for (and therefore
had switched off) TRIM32 expression. These cells showed the
characteristics of quiescent muscle stem cells as observed on
resting myofibers. It is reasonable to propose that this subset of
cells corresponds to the self-renewing population that goes on to
replenish the satellite cell pool on the myofiber [16] and that the
down-regulation of TRIM32 occurs prior to these cells taking up
their quiescent state.
These observations fit well with the established model for
satellite cell lineage progression that is regulated through the
balance of MyoD and Pax7 protein expression within the satellite
cell [23][24]. A similar ratio of Pax7:MyoD within the myoblast is
necessary for satellite cell proliferation, a situation that we observe
in the presence of low levels of TRIM32. However, as TRIM32
expression increases within the majority of myoblasts, it acts to
ubiquitinate c-Myc causing its breakdown and thus the c-Myc
inhibition of MyoD expression [22] is lost. As a consequence,
MyoD expression levels increase within the cell and the ratio of
Pax7:MyoD is reduced, thus inhibiting proliferation and inducing
differentiation through Myogenin expression. In the absence of
TRIM32, this balance of Pax7:MyoD is dysregulated, because
degradation of c-Myc is not initiated, MyoD levels do not increase
and Myogenin expression is not activated. Consequently,
differentiation of the satellite cells is impaired or delayed.
Interestingly, we also found that TRIM32 is expressed during
foetal skeletal muscle development in both differentiating progeny
cells and newly formed myofibers (Fig. S3), suggesting the role for
TRIM32 in adult skeletal muscle may be re-capitulated in the
embryo. Nevertheless, compensatory proteins must enable the
development of skeletal muscle in the absence of TRIM32.
We have shown that TRIM32 is expressed in both proliferating
and differentiating satellite cell progeny. Since in the absence of
Figure 6. Loss of TRIM32 function causes an increase in muscle satellite cells and their mislocalization. (a) Immunostainings with
antibodies against different MHC isoforms shows no changes in TA muscle morphology and fiber composition between one month-old wild type (+/
+) and TRIM32 deficient mice (2/2). (b–e) Immunostainings of muscle satellite cells in TA muscle sections from one month-old wild type (+/+) and
TRIM322/2 (2/2) mice labelled for the indicated markers. Arrows in (d) indicate two satellite cells located beneath the basal lamina and the arrow in
(e) indicates one satellite cell located outside the basal lamina.
doi:10.1371/journal.pone.0030445.g006
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+ muscle stem cells fail to differentiate (Fig. 3), one
may hypothesise that this lack of differentiation could lead to
tumour formation. However, we never observed tumours in the
muscle or any other tissue in TRIM32 knock-out mice. The reason
for this initially surprising observation is probably that once
satellite cells become activated, they are unable to develop further
into a more differentiated state and instead undergo apoptosis
following the loss of TRIM32 expression. Such a vertebrate-
specific protection mechanism to prevent tumourigenesis in
response to stem cell over-proliferation has been suggested
previously [25]. However, the underlying molecular mechanism
is still not clear.
We show that despite TRIM322/2 satellite cells being delayed
in their differentiation program, they nevertheless eventually form
some differentiated cell progeny. These results would seem to be
contradictory. However, due to the intimate link between
proliferation and differentiation, particularly in the myogenic
lineage, we suggest the following possible explanations. Firstly, in
Figure 7. TRIM322/2 mice show delayed and impaired skeletal muscle regeneration. (a)–(d) H&E staining of transverse cross sections
through CTX-injured TA muscles 5 days post injection from wild type (a) and (c) and TRIM322/2 (b) and (d) mice. (c) and (d) show enlarged regions of
the boxed areas in (a) and (b), respectively. (e)–(h). H&E staining of transverse cross sections through CTX-injured TA muscles 16 days post injection
from wild type (e) and (g) and TRIM322/2 (f) and (h) mice. (g) and (h) show enlarged regions of (e) and (f), respectively. Arrow in (g) indicates
centrally nucleated myofiber characteristic of efficient muscle regeneration in wild type TA. In contrast, some regions of injured TRIM322/2 TA
display small centrally nucleated myofibers (h, arrowhead), adipocyte-like cells (f, arrow) or fibrosis (h, arrow).
doi:10.1371/journal.pone.0030445.g007
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expansion of the satellite cell population must take place.
We have observed that in the absence of TRIM32 initial lack of
differentiation does occur and that the affected satellite cells fail to
initiate appropriate Myogenin expression. It is well established that
satellite cells, when given the correct cues, are able to differentiate
into other cell types including adipocytes [26], therefore we cannot
rule out the possibility that lineage conversion is taking place in a
subset of TRIM322/2 satellite cells. Secondly, we have also
observed the necessity for MyoD, a member of the myogenic
regulatory factor family of proteins essential for normal rates of
myoblast differentiation, in the proliferation of the myoblast pool.
Therefore, if TRIM32 is acting to induce differentiation through
the indirect upregulation of MyoD and subsequently Myogenin, its
absence may perturb levels of differentiation through preventing
MyoD levels to build up in the cell. It is clear that Myogenin
expression does occur (albeit at a lower frequency) in the absence
of TRIM32. Therefore other factors may compensate for the loss
of TRIM32 and enable this process to occur, even though these
factors do not enable normal numbers of differentiated progeny to
develop.
We showed that TRIM32-induced differentiation involves the
poly-ubiquitination of c-Myc within muscle progenitor cells. The
knock-down of c-Myc alone is not sufficient to induce differen-
tiation. Therefore one could speculate that additionally to c-Myc,
other proteins have to be ubiquitinated by TRIM32. However,
because the overexpression of a mutant of TRIM32 that is no
longer able to ubiquitinate, together with a knock-down of c-Myc
was sufficient to induce differentiation, this possibility seems to be
unlikely. Together these data demonstrate that a TRIM32
mediated reduction in the levels of c-Myc (via poly-ubiquitination)
is necessary but not sufficient for induction of differentiation.
Previously we have shown that TRIM32 also binds to Argonaute-1
and that this binding leads to the activation of the micro-RNA Let-
7a [7]. Therefore it is possible that activation of micro-RNAs by
TRIM32 is also critical for muscular differentiation. However
unlike in neural progenitor cells, in C2C12 cells the expression of
Let-7a is not sufficient to induce muscular differentiation (data not
shown). Nevertheless, this does not rule out the possibility that
activation of micro-RNAs other than Let-7a are necessary for
myoblast differentiation. Finally, we demonstrate that in the
absence of TRIM32, myogenic regeneration is greatly perturbed
highlighting the importance of TRIM32 specifically in this
process. Moreover, key phenotypic features of TRIM322/2
regenerating muscle correlate well with our in vitro data. Firstly,
regeneration is delayed and it takes longer for TRIM322/2
myofibers to reach the same size as their wild type equivalents.
Therefore, the number of cells undergoing myogenic differentia-
tion must be reduced in vivo. Secondly, regions of skeletal muscle
progenitors and/or cellular infiltrate persist in the tissue in the
absence of TRIM32 (noted at 16 days post injury – Fig. 7), far
beyond the time when wild type regeneration has been completed
(approximately 10 days) suggesting that these cells have failed to
differentiate even by this late stage. Finally, we noted the presence
of regions containing adipocyte-like cells within the skeletal muscle
tissue at 16 days post injury in the absence of TRIM32. These data
suggest that when the differentiation potential of myoblasts is
perturbed through loss of TRIM32, these residual pockets of
myoblasts may take up a separate adipogenic lineage. The fact that
these cells become adipocytes and not myofibroblasts, connective
tissue or endothelial tissue is not surprising, as recently links
between the myogenic and adipogenic lineages have been realised
with brown fat and skeletal muscle sharing common ancestry [27].
These data clearly demonstrate that TRIM32 is necessary for
satellite cell-mediated skeletal muscle regeneration and suggest
that the neuronal phenotype observed in the TRIM322/2 mouse
[18] is not the only causative reason for the apparent myopathy.
To summarise, this study has demonstrated that the ubiquitin
ligase TRIM32 plays a key role in lineage progression of satellite
cells and is essential for their differentiation thus expanding our
knowledge about how satellite cell-mediated skeletal muscle
regeneration is regulated. Moreover, we provide an explanation
for the phenotype observed in LGMD2H, thus greatly enhancing
our understanding of this pathology and therefore providing new
avenues of research into potential therapies of this disease.
Materials and Methods
Plasmids
The following plasmids were used: pEGFP-N1 (Clontech),
pEGFP-TRIM32 [7], pEGFP-TRIM32 C24A [7], pEGFP-
TRIM32 D489N (generated by side directed mutagenesis from
wildtype TRIM32) pRetroSuper c-Myc shRNA (Martin Eilers),
pcDNA3 c-Myc (Martin Eilers), pRNAT-H1.4 TRIM32-shRNA
#1 (GenScript) and pRNAT-H1.4 TRIM32-shRNA #2 (Gen-
Script).
Generation of Mice Deficient for TRIM32
The mouse TRIM32 genomic fragments were PCR-amplified
from the genomic DNA of R1 ES cells (on 129S1 background)
with a high fidelity polymerase from Clontech to build a gene-
targeting vector, which was designed to replace a 5 kb genomic
fragment containing exon 2 of TRIM32 with an SA-IRES-bgeopA
expression cassette. Southern blot analysis was carried out to
screen for the presence of a disrupted TRIM32 locus using
BamH1/Kpn1 (for the 59 external probe) and Nsi1 digestion (for the
39 external probe). We used two independently targeted ES cell
clones to generate chimeric mice that subsequently were bred with
129S1 females to obtain germ-line transmission. The phenotypes
of TRIM322/2 mutants derived from both targeted ES cell lines
were indistinguishable. All the shown experiments have been
conducted with those mice. All mouse experiments were
performed in accordance with procedures approved by the
University of Manitoba Animal Care and Use Committee.
Additionally, TRIM32-null mice that have been described
recently [18] were used to repeat and verify the results shown in
Figures 3, S1 and S6.
Cardiotoxin (CTX)-induced muscle injury and
regeneration
25 ml CTX (10 mM; Latoxan) were injected into the tibialis
anterior (TA) or the gastrocnemius muscles of mice. Mice were
sacrificed and the injected muscle tissues were collected at the
indicated time points,fixed with formalin overnight and embedded
in paraffin. Sections were stained with hematoxylin-eosin.
Myofiber culture (mice)
The isolation and culture of myofibers has been described
previously [19]. Briefly, EDL muscles were dissected and placed in
0.1% collagenase type I (Sigma) in DMEM and incubated for
approximately 1.5 h at 37uC. Using graded glass pipettes,
myofibers were liberated from the muscle bulk, washed in DMEM
and either fixed in 4% Paraformaldehyde (PFA) in PBS for 15 min
or cultured. For myofiber culture, single isolated myofibers were
placed in floating culture in 24 well plates with 2–4 fibers per well
in 0.5 ml single fiber culture medium (SFCM - DMEM containing
GLUTAMAX, 100 mg/ml penicillin streptomycin, 10% (v/v)
horse serum and 0.5% (v/v) chick embryo extract) at 37uC, 5%
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PBS for 15 min and processed for immunocytochemistry.
Myofiber culture (Callithrix jacchus)
Marmoset monkeys (Callithrix jacchus) were raised in the
institutional breeding facility of the Centre of Reproductive
Medicine and Andrology. Breeding (Prof. Dr. Stefan Schlatt),
maintenance and experimental procedures were performed in
accordance with the German Federal law on the Care and Use of
laboratory animals. A license for the marmoset breeding colony
was obtained from local authorities (Veterina ¨r- und Lebensmitte-
lu ¨berwachungsamt der Stadt Mu ¨nster). The license to sacrifice
marmosets as tissue donors for scientific experiments was granted
by the Landesamt fu ¨r Natur, Umwelt und Verbraucherschutz
Nordrhein-Westfalen (8.87–50.10.46.09.018). The animals were
deeply sedated using ketamine and killed by exsanguination.
Muscle tissue from adult marmosets was obtained from local
colonies at the Institute of Reproductive Medicine, University of
Mu ¨nster. Cultures of myofibers from this tissue were obtained and
treated as described above for the mouse tissue.
Immunohistochemistry and RNA in situ hybridization
Fixed myofibers or muscle tissue cryosections were permeabi-
lised in a solution of 20 mM Hepes, 300 mM sucrose, 50 mM
NaCl, 3 mM MgCl2 and 0.5% Triton-X100 (pH 7) at 4uC for
15 min. Fibers were washed in PBS and non-specific binding was
blocked using wash buffer (5% (v/v) Foetal Calf Serum (FCS)/PBS
with 0.05% (v/v) Triton-X100) for 30 min. The following primary
antibodies were used: anti-Pax7 (Neuromics, 1:100), polyclonal
rabbit anti-MyoD (Santa Cruz Biotechnology-M-318, 1:200),
polyclonal rabbit anti-Myogenin (Santa Cruz Biotechnology-M-
225, 1:200) and anti-Myosin Heavy Chain (A4.1025, develop-
mental studies hybridoma bank 1:4). Alexa-fluorophore conjugat-
ed antibodies (Invitrogen) and HRP-coupled secondary antibodies
(MoBiTec) were used for visualisation. The rabbit anti-TRIM32
antibody (1137, directed against the N-Terminus of the protein)
was described previously [7]. This antibody was used to detect
TRIM32 when nothing else is indicated. Additionally, we used a
commercially available anti-TRIM32 antibody (M09, Abnova;
Fig. S1b) and a self-made anti-TRIM32 antibody (3150; Fig. S1c)
directed against the C-terminal part of the protein (peptide
antigen: VKIYSYHLRRYSTP).
All antibodies were diluted in wash buffer and samples were
incubated in primary antibodies for 18 h at 4uC. The anti-rabbit
secondary antibody was incubated for 1 h at room temperature
and all fluorescent antibody labeling was carried out at room
temperature for 45 minutes. Myofibers and tissue sections were
mounted using fluorescent mounting medium (DakoCytomation).
Nuclear visualization was carried out through either DAPI
(2.5 mg/ml) or Hoechst 33258 (Invitrogen) DNA stains.
RNA in situ analysis of frozen sections of mouse muscles were
performed according to established protocols [28], with sense and
antisense digoxigenin-labeled riboprobes which were in vitro
transcribed from the full-length mouse TRIM32 coding sequence.
C2C12 cell cultures
C2C12 cells were grown in DMEM supplemented either with
15% heat-inactivated FCS (proliferation) or 2.5% heat-inactivated
HS (differentiation), 2 mM L-glutamine, 100 U/ml penicillin and
100 mg/ml streptomycin. The cells were transfected with Fugene6
(Roche) according to the instructions of the manufacturer. C2C12
cells were processed for immunohistochemistry by fixation with
4% PFA in 120 mM phosphate buffer, pH 7.4 (PBS), permeabi-
lized with 0.05% Triton X-100 in PBS, blocked with 10% fetal calf
serum in PBS and subjected to immunohistochemistry stainings
with primary antibodies diluted in blocking solution. Images were
collected by confocal microscopy using LSM software (Zeiss);
image analysis was performed with the LSM software, Adobe
Photoshop and the IMAGE J software. For Western Blotting
C2C12 cells were lysed after two days of cultivation under
proliferation or differentiation conditions with lysis buffer 1 (2%
Triton X-100 and Complete protease inhibitor cocktail (Roche) in
PBS) for 30 min at 4uC. For qPCR analysis C2C12 cells were
lysed after two days of cultivation under proliferation or
differentiation conditions. The total mRNA was isolated with the
miRNeasy Kit (Quiagen) and qPCR was performed with
commercially available probes (Sigma) specific for TRIM32 or
GAPDH (control).
Immunoprecipitation and Western Blot
For the ubiquitination assay, C2C12 cells were transfected using
Turbofect (Fermentas) according to the manufacturer’s instruc-
tions and were lysed 48 h after transfection with nuclear lysis
buffer containing 50 mM TRIS (pH 7.5), 0.5 M NaCl, 1% NP-
40, 1% DOC, 0.1% SDS, 2 mM EDTA and complete protease
inhibitor (Roche) in H2O for 30 min at 4uC. After lysis of the cells,
the percentage of SDS was reduced to 0.07% by adding TRIS/
EDTA. For immunoprecipitation, the cell lysates were incubated
with the precipitation antibody for 4 h at 4uC and overnight with
protein-G Agarose beads (GE Healthcare). Afterwards, bound
proteins were eluted by boiling in protein sample buffer.
For immunoprecipitation assays from differentiated cells,
C2C12 cells were differentiated 24 h after transfection using
DMEM supplemented with 2.5% heat-inactivated HS, 2 mM L-
glutamine, 100 U/ml penicillin and 100 mg/ml streptomycin.
24 h after differentiation, the cells were incubated with a final
concentration of 10 mM of the proteasome inhibitor MG-132
(Sigma) for 7 h before lysis.
To ensure loading of equal amounts of protein for SDS-PAGE
and Western Blotting the total concentration of proteins was
determined with a BCA protein assay kit (Thermo Scientific)
according to the manufacturer’s instructions. Furthermore, equal
amounts of blotted protein were verified by Ponceau S (Sigma)
staining on the membrane. Analysis of Western Blots was done
using Image J software.
Supporting Information
Figure S1 Coexpression of TRIM32 and MyoD or
Myogenin and absence of TRIM32 in myofibers of
TRIM322/2 mice. (a) Immunostainings of myofibers from
wild type mice cultured for 0 h and labelled with the indicated
markers (upper grey boxes). Note that here the anti-TRIM32-1137
antibody has been used. (b) Immunostainings of satellite cells on
myofibers from wild type mice cultured for the indicated time (left
grey boxes) and labelled with the indicated markers (upper grey
boxes). Note that here the anti-TRIM32 antibody M09 has been
used. (c) Immunostainings of satellite cells on myofibers from wild
type (+/+) and TRIM322/2 (2/2) mice labelled with the
indicated markers (upper grey boxes). Note that here the anti-
TRIM32 antibody 3150 has been used.
(TIF)
Figure S2 The expression pattern of TRIM32 is con-
served in the Common Marmoset Callithrix jacchus.
Immunostainings of satellite cells on Marmoset myofibers cultured
for 24 h and labelled with the indicated markers (upper grey
boxes).
(TIF)
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opment. (a) Immunostainings of cross sections from wild type
E14.5 Lower Hindlimb and E18.5 EDL Muscle labelled with the
indicated markers (upper grey boxes). (b) Immunostainings of cross
sections from wild type E18.5 EDL Muscle labelled with the
indicated markers (upper grey boxes).
(TIF)
Figure S4 Gene-targeting strategy for creating the
TRIM32 null allele. (a) Schematic representation of the
TRIM32 genomic locus, the gene-targeting vector and the mutated
locus with Exon 2 replaced by the SA-IRESbgeo cassette. (b)
Southern Blot analysis of ES clones with insertion of targeting
vector. Both 59 and 39 probes gave predicted digestion patterns. (c)
Western Blot analysis of TRIM32 expression in cell lysates from
mouse embryonic fibroblast derived from TRIM32 knock-out
mice, demonstrating complete loss of TRIM32 expression in
TRIM322/2 cells.
(TIF)
Figure S5 Expression of TRIM32 is upregulated during
differentiation of C2C12 cells. (a) Immunostainings of C2C12
cells cultivated for 0 days, two days or 5 days under differentiation
conditions and labelled with the indicated markers (upper grey
boxes). (b) Western Blot analysis of TRIM32 expression in C2C12
cells cultivated for 0 days, two days or 5 days under differentiation
conditions. (c) Diagram showing the relative levels of TRIM32
protein in C2C12 cells (Western Blot measurement as in (c))
cultivated under differentiation conditions. Ponceau S staining was
used to normalize the protein levels.
(TIF)
Figure S6 Increased apoptosis in satellite cells of
TRIM322/2 mice. (a) Immunostainings of satellite cells on
myofibers from wild type (+/+) and TRIM322/2 (2/2) mice
cultured for 24 h and labelled with the indicated markers (upper
grey boxes). (b) Diagram showing the fraction of satellite cells on
myofibers of wild type (+/+) and TRIM322/2 (2/2) mice
undergoing apoptosis (cleaved Caspase 3 positive) at 24 h, 48 h
and 72 h.(mean 6 std; *P,0.001 compared to wild type).
(TIF)
Figure S7 TRIM32 binds to and ubiquitinates c-Myc in
C2C12 cells. (a) Western blot analysis of C2C12 cells transfected
with the indicated constructs and immunoprecipitation of c-Myc
with an anti-c-Myc antibody. Antibodies against c-Myc and HA
were used for detection of ubiquitinated c-Myc after immunopre-
cipitation and an antibody against EGFP was used to detect the
different TRIM32 constructs (arrow) that bound to c-Myc. In the
lysate, the different TRIM32 constructs (arrow) and EGFP were
detected with an anti-EGFP-antibody. Unspecific bands are
indicated by asterisks. The GAPDH western blot is shown as
loading control. (b) Western blot analysis of C2C12 cells
transfected with HA-tagged Ubiquitin and cultivated for two days
under differentiation conditions. The cells were treated for seven
hours with the proteasome inhibitor MG-132 and c-Myc was
immunoprecipitated using an anti-c-Myc antibody. Antibodies
against c-Myc and mono- and poly-ubiquitinated proteins were
used for detection of ubiquitinated c-Myc after immunoprecipi-
tation.
(TIF)
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